OrthoAccel Continues Growth and Company Expansion Within The Orthodontic Technology Realm
HOUSTON, TX, August 4, 2008
– OrthoAccel Technologies, Inc., (OATI), creator of a potentially game-changing device for orthodontics that is being studied to verify that it reduces treatment duration for wearing braces, continues its company growth with the new addition of Bill Ryan to the OrthoAccel Board of Directors.
As the former President and CEO of The Straumann Company and NobelPharma USA Inc., both dental implant companies, Bill’s 40-year career includes numerous executive general management roles at leading biotechnology and pharmaceutical companies, including Repligen and Pharmacia, with past academic board appointments at School of Dental Medicine at the University of Pennsylvania and Harvard School of Dental Medicine.>/br>
Mike Lowe, President and CEO of OrthoAccel, said, “We are very pleased to have Bill’s insight, expertise, and experience folded into what we are doing at OrthoAccel. Within the dental implant industry, he has faced and successfully overcome many of the same challenges that we will be encountering as it relates to developing and commercializing breakthrough dental technologies. We’ve already felt his positive impact in the short time since we engaged him.”
Bill Ryan said, “I am very pleased to be a member of the Board of Directors for OrthoAccel Technologies. The technology presents a significant breakthrough in a rich and rapidly growing market and as a result, the market potential is huge. More importantly, I am convinced that the senior management of Mike Lowe and Brent Tarver have the experience and vision to exploit this potential to the fullest.”
In addition, OrthoAccel launched its new and informational website this month. For more details, visit www.acceledent.co.uk
Based in Houston, Texas, OrthoAccel Technologies, Inc., (OATI), is the creator of a potentially game-changing device for orthodontics. This device is being studied to verify that it reduces treatment duration for wearing braces by applying cyclic forces in combination with standard orthodontics to move teeth faster through accelerated bone remodeling. Importantly, the device works complimentary with all existing orthodontic technologies. With an expected launch of this innovative and patented product in 2010, the company has established a Scientific Advisory Board and was a recipient of BioHouston’s 2007 Michael E. DeBakey Life Science Award for outstanding commercial and clinical opportunity.
For more information, please contact Mike Lowe at firstname.lastname@example.org or visit www.acceledent.co.uk